Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03316066
Other study ID # Maisonneuve RH
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date October 20, 2018
Est. completion date February 21, 2020

Study information

Verified date February 2020
Source Maisonneuve-Rosemont Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the efficiency and safety of 2ml versus 5ml of local anesthetics used in stellate ganglion blocks for the treatment of complex regional pain syndrome of the arm.


Description:

To evaluate if 2ml of 0.2% ropivacaine is less effective in decreasing pain scores by more than 50% when compared to 5ml of 0.2% ropivacaine. To evaluate if 2ml of 0.2% ropivacaine is causes less side effects when compared to 5ml after a stellate ganglion block.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date February 21, 2020
Est. primary completion date February 21, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with a diagnosis of complex regional pain syndrome of the arm according to the Budapest criteria and having already received a minimum of 3 stellate ganglion blocks. Only patients having received a minimum of 3 stellate ganglion blocks will be included since it is expected to have a progressive and sustained decrease in pain scores during the first 3 blocks.

- ASA 1 to 3 included

Exclusion Criteria:

- Patient refusal

- Contra-indications to the stellate ganglion block procedure such as coagulopathy, anticoagulants or anti platelet therapy other than aspirin, systemic or injection site infection, important neck deformity (post-radiotherapy or surgery, etc.), severe chronic obstructive pulmonary disease, contralateral diaphragm paralysis or contralateral pneumonectomy

- Allergy to local anesthetics

- Concomitant pain syndrome other than complex regional pain syndrome of the arm

- Liver or kidney failure (CrCl < 30 ml/min)

- Inability to understand à verbal numeric pain score scale after careful explanations

- Inability to consent

Study Design


Intervention

Procedure:
stellate ganglion block with ropivacaine 0.2% 5 mL
Each patient will undergo two stellate ganglion blocks and receive both volumes of local anesthetics in random order. The stellate ganglion blocks will be separated by 3 weeks in order to assure that no residual effects from the previous block will influence the results.
stellate ganglion block wit ropivacaine 0.2% 2 mL
Each patient will undergo two stellate ganglion blocks and receive both volumes of local anesthetics in random order. The stellate ganglion blocks will be separated by 3 weeks in order to assure that no residual effects from the previous block will influence the results.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Maisonneuve-Rosemont Hospital

Outcome

Type Measure Description Time frame Safety issue
Other Occurrence of seizure during a stellate ganglion block patient having seizure within 30 minutes of performing the stellate ganglion block
Other Occurrence of hematoma after a stellate ganglion block physician or patient identifying a neck hematoma During the first 7 days after the procedure
Other Occurrence of pneumothorax after a stellate ganglion block physician diagnosing a pneumothorax During the first 7 days after the procedure
Primary Pain score Evaluate the efficiency of stellate ganglion block in decreasing pain scores 24 hours after the procedure using a verbal numeric pain rating scale. 24 hours after the stellate ganglion block
Secondary Pain score Evaluate the efficiency of stellate ganglion block in decreasing pain scores 7 days after the procedure using a verbal numeric pain rating scale. 7 days after the stellate ganglion block
Secondary Pain score Evaluate the efficiency of stellate ganglion block in decreasing pain scores 14 days after the procedure using a verbal numeric pain rating scale. 14 days after the stellate ganglion block
Secondary Temperature increase in the ipsilateral arm Evaluate the efficiency of stellate ganglion block on the increase in temperature of the ipsilateral arm using an infrared thermometer. The cutaneous temperature will be measured in order to determine the proportion of patients in each group reaching an increase of >1.5 C in the ipsilateral arm. 1 hour after the procedure
Secondary Horner Syndrome Evaluate the efficiency of stellate ganglion block to produce an ipsilateral Horner Syndrome as defined by a ptosis and miosis. Evaluate the proportion of patients in each group presenting an ipsilateral Horner syndrome. 1 hour after the procedure
Secondary Occurrence of dysphagia after a stellate ganglion block Patients describing having dysphagia after the stellate ganglion block 1 hour after the procedure
Secondary Occurrence of hoarseness after a stellate ganglion block patients describing having hoarseness after a stellate ganglion block 1 hour after the procedure
Secondary Occurrence of foreign body sensation after a stellate ganglion block patients describing having a foreign body sensation after the stellate ganglion block 1h after the procedure
Secondary Occurrence of dyspnea after a stellate ganglion block patients describing having dyspnea after a stellate ganglion block 1h after the procedure
Secondary Occurrence of ipsilateral arm weakness after a stellate ganglion block patients describing having ipsilateral arm weakness after a stellate ganglion block 1h after the procedure
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04066933 - Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
Completed NCT04597866 - Treatment of Complex Regional Pain Syndrome, a Long-term Follow-up
Completed NCT04060875 - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Not yet recruiting NCT06453447 - Prednisone for CRPS in Distal Radius Fracture N/A
Terminated NCT01954888 - Impact of the Ultrasound-guided Approach on the Efficiency and Safety of the Stellate Ganglion Block in Chronic Pain N/A
Terminated NCT00689585 - Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Phase 2
Recruiting NCT00377468 - Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) Phase 2
Recruiting NCT05787119 - Benefit of Augmented Reality Mirror Therapy in Addition to Conventional Management in Complex Regional Pain Syndrome of the Upper Extremity N/A
Recruiting NCT05523934 - Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome
Recruiting NCT04732325 - Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain N/A
Completed NCT03174249 - Exposure Therapy Combined With Cortical Interventions for CRPS-II N/A
Recruiting NCT06033456 - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome N/A
Recruiting NCT04144972 - Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain N/A
Completed NCT02490436 - Novel Treatment Option for Neuropathic Pain Phase 2
Recruiting NCT05491499 - Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes
Completed NCT03291197 - Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome Phase 4
Recruiting NCT05034835 - Impact of Compression Garments on Pain in Patients With Complex Regional Pain Syndrome of the Upper Limbs. N/A
Completed NCT05696587 - Physical and Psychological Changes in CRPS Patients Undergoing Multimodal Rehabilitation N/A
Recruiting NCT02957240 - Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures N/A
Terminated NCT00891397 - Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) N/A